
Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial
Author(s) -
Zhu SiYuan,
Ma Ding,
Ye FuGui,
Shao ZhiMing,
Yu KeDa
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.513
Subject(s) - carboplatin , medicine , regimen , oncology , triple negative breast cancer , breast cancer , taxane , epirubicin , anthracycline , cancer research , cancer , chemotherapy , cisplatin